FDAnews Drug Daily Bulletin

AMGEN GETS PRIORITY REVIEW FROM FDA, PLANS TO TRIPLE STAFF IN JAPAN TO SELL ITS OWN DRUGS

June 14, 2006
A A

Amgen Inc. said that Food and Drug Administration has granted priority review of its panitumumab treatment for patients with metastatic colorectal cancer in an announcement Monday after the market closed, and also announced Tuesday that it will triple the number of its employees in Japan by 2010 to begin selling its new cancer drugs on its own. Los Angeles Business (http://losangeles.bizjournals.com/losangeles/stories/2006/06/12/daily18.html)